LC SCIENCES

Company Snapshot

Founded: 2004
Entity Type: Private
Region: U.S.
Headquarter: Texas, U.S.
Key Geographics: U.S.
Corporate Address: 2575 West Bellfort Street, Suite 270 Houston, Texas 77054 U.S. Tel. +1-713-664-7087 www.lcsciences.com

Company Overview

L.C. Sciences offers genomics and proteomics products and services related to research for the development of nucleic acid/protein analysis, biomarker-discovery, and drug development. The company offers products for genomics, transcriptomics, proteomics and metagenomics, and DNA/RNA sequencing, microarray, and bioinformatics services. OligoMix is a cost-effective technology that can increase the speed of highly multiplexing genome-scale experiments. This technology is used for the development of libraries for various biomolecules, sequence capture, FISH application and synthetic biology. L.C. Sciences offers technologies and novel products to researchers, which can be used for genomics and proteomics analysis.

LC SCIENCES In Reports

Oligonucleotides: Global Markets

BCC Research Market Analyst says global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028 at a CAGR of 11.0%.

Synthetic Biology: Global Markets

BCC Research Market Report for synthetic biology is estimated to increase from $9.5 billion in 2021 to $33.2 billion by 2026, at a compound annual growth rate of 28.4%

Oligonucleotides: Global Markets to 2026

BCC Research Market Report says oligonucleotide synthesis should grow from $6.1 billion in 2021 to $10.2 billion by 2026 with a CAGR of 10.7%

Company's Business Segments

  • Genomics and Proteomics : The company provides DNA sequencing, RNA sequencing, and bioinformatics services, along with expertise in transcriptomics and other areas of molecular research.

Applications/End User Industries

  • Life Sciences
  • Synthetic Biology
  • Drug Development
  • Biotechnology Research
  • Genomics Researchers
  • Proteomics Researchers
  • Peptide Arrays
  • RNA Sequencing
  • Oligonucleotide Synthesis
AI Sentiment